Case of Mistaken Identity Leads to Much-Needed Drug Target Against MRSA, Gram-Positive Infections
February 3rd 2015Scientists at the University of Utah and the University of Georgia have uncovered a pharmacological target that could enable development of novel drugs against antibiotic-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and other infectious Gram-positive organisms such as Listeria and Mycobacterium tuberculosis. The target was revealed upon discovery of a Gram-positive bacteria-specific pathway for making heme, an essential iron-carrying molecule. The findings were reported in the journal Proceedings of the National Academy of Sciences (PNAS).
Study Shows How Immune Cells Hone Their Skills to Fight Disease
February 2nd 2015The last time you were in the doctor’s office for a vaccine booster shot, did you wonder why you needed one? Exactly how booster shots offer long-term protection from viruses has long been a mystery to scientists. Now, a new study from scientists at The Scripps Research Institute (TSRI) helps explain how booster shots prompt immune “memory” to improve, an important step toward the development of more effective, longer-lasting vaccines. The findings were published online ahead of print on Feb. 2 in the journal Nature Immunology.
Virginia Tech Researcher Seeks Better Ways to Prevent Flu
February 2nd 2015Linsey Marr, a professor in the Charles E. Via Jr. Department of Civil and Environmental Engineering at Virginia Tech, is obsessed with flu transmission. This time of year, she’s not alone. Hand sanitizers and cough drops abound, and banners outside drugstores and doctors’ offices proclaim, “Get your flu shot.”
CDC Issues Guidance for Labs Managing and Testing Routine Clinical Specimens for Ebola
January 31st 2015Clinicians should maintain a high index of suspicion and consult their local and state health departments and CDC when ill travelers from Ebola-affected countries are identified; it is important to recognize that the likelihood of EVD even among symptomatic travelers returning from these countries is very low. In the hospital setting, where policies and procedures should be in place to safeguard health care workers, consideration of Ebola should not delay diagnostic assessments, laboratory testing, and appropriate care for other, more likely medical conditions.
Latent HIV May Lurk in 'Quiet' Immune Cells, Research Suggests
January 30th 2015Drugs for HIV have become adept at suppressing infection, but they still can't eliminate it. That's because the medication in these pills doesn't touch the virus' hidden reserves, which lie dormant within infected white blood cells. Unlock the secrets of this pool of latent virus, scientists believe, and it may become possible to cure -- not just control -- HIV.
Steady as She Goes: The Case for Daily Patient Bathing as Part of a Bundled Intervention Protocol
January 30th 2015In a recent study published in the Journal of the American Medical Association (JAMA)1, Noto et al. found that in a “single-center, multi-ICU, cluster randomized, crossover study, once daily bathing with chlorhexidine did not reduce the rate of the composite primary outcome of infections including central-line associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), possible or probable ventilator-associated pneumonia (VAP), or infection with C difficile.” The authors further concluded that these findings do not support daily bathing of critically ill patients with chlorhexidine.
Research Uncovers Connection Between Craigslist Personals, HIV Trends
January 30th 2015Craigslist's entry into a market results in a 15.9 percent increase in reported HIV cases, according to research from the University of Minnesota published in the December issue of MIS Quarterly. When mapped at the national level, more than 6,000 HIV cases annually and treatment costs estimated between $62 million and $65.3 million can be linked to the popular website.